Reasons why Aclaris Therapeutics Inc’s (NASDAQ:ACRS) fundamentals are futile
In Friday’s Wall Street session, Aclaris Therapeutics Inc (NASDAQ:ACRS) shares traded at $1.26, unchanged from the previous session. ACRS stock price is now -6.79% away from the 50-day moving average and -33.79% away from the 200-day moving average. The market capitalization of the company currently stands at $136.43M. On December 23, 2024, H.C. Wainwright Upgraded […]
Do you still think Aclaris Therapeutics Inc (NASDAQ:ACRS) is worth a look?
In yesterday’s Wall Street session, Aclaris Therapeutics Inc (NASDAQ:ACRS) shares traded at $4.59, up 46.18% from the previous session. ACRS stock price is now 187.31% away from the 50-day moving average and 251.72% away from the 200-day moving average. The market capitalization of the company currently stands at $327.86M. With the price target enhanced from […]
Before Investing In Aclaris Therapeutics Inc (NASDAQ:ACRS), Here Are Some Things To Consider
The stock of Aclaris Therapeutics Inc (NASDAQ:ACRS) last traded at $1.69, up 31.01% from the previous session. ACRS stock price is now 41.04% away from the 50-day moving average and 40.47% away from the 200-day moving average. The market capitalization of the company currently stands at $120.56M. , while ‘Evercore ISI’ rates the stock as […]